Expression of cyclooxygenase-2, 12-lipoxygenase, and inducible nitric oxide synthase in head and neck squamous cell carcinoma

J Craniofac Surg. 2013 Jul;24(4):1114-7. doi: 10.1097/SCS.0b013e31828f2491.

Abstract

Aim: The objective of this study was to investigate whether cyclooxygenase-2 (COX-2), 12-lipoxygenase (12-LOX), and inducible nitric oxide synthase (iNOS) have a role in carcinogenesis of head and neck squamous cell carcinoma (HNSCC).

Materials and methods: Twenty-two patients with HNSCC were included in the study. Cancer tissues and adjacent normal mucosa were obtained from each patient. Real-time PCR was used to assess the expression of COX-2, 12-LOX, and iNOS.

Results: COX-2 and 12-LOX mRNA expressions are significantly increased in HNSCC compared with adjacent normal mucosa. Expression of iNOS was not significantly elevated in overall head and neck cancer tissues compared with normal mucosa. However, iNOS expression was found to be significantly elevated in patients with laryngeal cancer.

Conclusion: These data suggest that COX-2 and 12-LOX may play a role in carcinogenesis of head and neck cancer. iNOS as well as COX-2 and 12-LOX may play a role in carcinogenesis of laryngeal cancer.

MeSH terms

  • Adult
  • Aged
  • Arachidonate 12-Lipoxygenase / genetics
  • Arachidonate 12-Lipoxygenase / metabolism*
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism*
  • Carcinoma, Squamous Cell / enzymology*
  • Case-Control Studies
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism*
  • Female
  • Head and Neck Neoplasms / enzymology*
  • Humans
  • Laryngeal Neoplasms / enzymology*
  • Male
  • Middle Aged
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type II / metabolism*
  • RNA, Messenger / metabolism
  • Squamous Cell Carcinoma of Head and Neck

Substances

  • Biomarkers, Tumor
  • RNA, Messenger
  • Arachidonate 12-Lipoxygenase
  • NOS2 protein, human
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2